These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 21619050)

  • 1. Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer.
    Li J; Poi MJ; Tsai MD
    Biochemistry; 2011 Jun; 50(25):5566-82. PubMed ID: 21619050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a.
    Baumgartner R; Fernandez-Catalan C; Winoto A; Huber R; Engh RA; Holak TA
    Structure; 1998 Oct; 6(10):1279-90. PubMed ID: 9782052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and characterization of a hyperstable p16INK4a that restores Cdk4 binding activity when combined with oncogenic mutations.
    Cammett TJ; Luo L; Peng ZY
    J Mol Biol; 2003 Mar; 327(1):285-97. PubMed ID: 12614625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and characterization of Syrian golden hamster p16, a homologue of human tumor suppressor p16 INK4A.
    Li J; Qin D; Knobloch TJ; Tsai MD; Weghorst CM; Melvin WS; Muscarella P
    Biochem Biophys Res Commun; 2003 May; 304(2):241-7. PubMed ID: 12711305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic and biochemical analyses of p16(INK4a) mutations from primary tumors.
    Yarbrough WG; Buckmire RA; Bessho M; Liu ET
    J Natl Cancer Inst; 1999 Sep; 91(18):1569-74. PubMed ID: 10491434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Tumor Suppressor Gene CDKN2A and Encoded p16-INK4a Protein by Covalent Modifications.
    Jiao Y; Feng Y; Wang X
    Biochemistry (Mosc); 2018 Nov; 83(11):1289-1298. PubMed ID: 30482142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
    Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
    Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
    Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
    Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors.
    Romagosa C; Simonetti S; López-Vicente L; Mazo A; Lleonart ME; Castellvi J; Ramon y Cajal S
    Oncogene; 2011 May; 30(18):2087-97. PubMed ID: 21297668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Alterations in the INK4a/ARF Locus: Effects on Melanoma Development and Progression.
    Ming Z; Lim SY; Rizos H
    Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33076392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer.
    Zhao R; Choi BY; Lee MH; Bode AM; Dong Z
    EBioMedicine; 2016 Jun; 8():30-39. PubMed ID: 27428416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRIM-19 and p16(INK4a) synergistically regulate cell cycle progression and E2F1-responsive gene expression.
    Sun P; Nallar SC; Raha A; Kalakonda S; Velalar CN; Reddy SP; Kalvakolanu DV
    J Biol Chem; 2010 Sep; 285(36):27545-52. PubMed ID: 20522552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer.
    Kriegl L; Neumann J; Vieth M; Greten FR; Reu S; Jung A; Kirchner T
    Mod Pathol; 2011 Jul; 24(7):1015-22. PubMed ID: 21423154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes.
    Liu Y; Johnson SM; Fedoriw Y; Rogers AB; Yuan H; Krishnamurthy J; Sharpless NE
    Blood; 2011 Mar; 117(12):3257-67. PubMed ID: 21245485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular balancing act of p16(INK4a) in cancer and aging.
    LaPak KM; Burd CE
    Mol Cancer Res; 2014 Feb; 12(2):167-83. PubMed ID: 24136988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel frameshift mutation in the p16/INK4A tumor suppressor gene in canine breast cancer alters expression from the p16/INK4A/p14ARF locus.
    Lutful Kabir FM; Agarwal P; Deinnocentes P; Zaman J; Bird AC; Bird RC
    J Cell Biochem; 2013 Jan; 114(1):56-66. PubMed ID: 22833492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ageing as developmental decay: insights from p16(INK4a.).
    Martin N; Beach D; Gil J
    Trends Mol Med; 2014 Dec; 20(12):667-74. PubMed ID: 25277993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of wild-type and malignant glioma derived CDKN2Abeta alleles: evidence for an RB-independent growth suppressive pathway.
    Arap W; Knudsen E; Sewell DA; Sidransky D; Wang JY; Huang HJ; Cavenee WK
    Oncogene; 1997 Oct; 15(17):2013-20. PubMed ID: 9366518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages.
    Randle DH; Zindy F; Sherr CJ; Roussel MF
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9654-9. PubMed ID: 11481442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteine oxidation triggers amyloid fibril formation of the tumor suppressor p16
    Göbl C; Morris VK; van Dam L; Visscher M; Polderman PE; Hartlmüller C; de Ruiter H; Hora M; Liesinger L; Birner-Gruenberger R; Vos HR; Reif B; Madl T; Dansen TB
    Redox Biol; 2020 Jan; 28():101316. PubMed ID: 31539802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.